← Back to All Filings

UTHR Director Reports Minor Share Gift and Holding Correction

Low SignificanceOctober 27, 2025 at 4:32:09 PM EDT

UNITED THERAPEUTICS Corp

$UTHR4CIK: 0001082554

Subscribe to track UTHR

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

UTHR Director Reports Minor Share Gift and Holding Correction

Company: UNITED THERAPEUTICS Corp (UTHR) Form: 4 | Filed: 2025-10-27 Significance: Low

Insider: CAUSEY CHRISTOPHER Title: Director

Transaction: • Type: Gift (Disposition) • Shares: 225 • Price: $0.00 • Value: $0.00 • Owned After: 4,640

Key Insight: A corrective filing for a small, non-market gift of 225 shares. The transaction has no market value and is immaterial to the company's $18.9B market cap.

Market Context: The filing clarifies a past transfer from a joint account, correcting the director's reported beneficial ownership. This is an administrative action with no market signal.

Comprehensive Analysis

SEC Filing Analysis: UNITED THERAPEUTICS Corp (UTHR)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director filed a late Form 4 to report a small, non-market gift of 225 shares, which serves as a correction for a previous overstatement of holdings.
  • Market Impact: Negligible. This is an administrative filing with no market implications.

Company Information

FieldValue
CompanyUNITED THERAPEUTICS Corp
Ticker SymbolUTHR
CIK0001082554
IndustryPHARMACEUTICAL PREPARATIONS

Insider Information

FieldValue
NameCAUSEY CHRISTOPHER
CIK0001237334
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2024-09-09
Transaction CodeG (Gift)
Security TypeCommon Stock
Shares Involved225
Price Per Share$0.00
Total Value$0.00
Shares Owned After4,640
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0.00
% of Market Cap0.0%
Shares Transacted225
% of Shares Outstanding0.0005%
Post-Transaction Ownership4,640 shares (0.0103% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction is valued at $0 and involves a negligible number of shares for a company with an $18.93 billion market capitalization.
  • Ownership Concentration: The director's post-transaction ownership of 4,640 shares represents a very small fraction (~0.01%) of the total shares outstanding, indicating low influence from this holding.
  • Dilution Impact: Not applicable, as this was a disposition of existing shares, not an issuance of new equity.
  • Transaction Significance: The transaction is a non-market gift with zero value. Its primary purpose, as noted in the filing's footnotes, is to correct the record for a transfer that occurred previously without the insider's knowledge. It holds no significance as a trading signal.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: A non-market, zero-value gift and corrective filing has no bearing on the company's fundamentals, operations, or stock price. It is purely an administrative disclosure.

Volume & Sentiment

  • Expected Volume Impact: None. The market will not react to this type of filing.
  • Sentiment Indicator: Neutral. This filing does not provide any information that would influence investor sentiment.

Investment Insights

Positive Market Indicators

  • None can be derived from this filing.

Risk Factors

  • The late filing itself represents a minor administrative lapse, but the underlying transaction is inconsequential.

Key Takeaways

  1. Administrative Correction: This is a corrective filing for a past transaction, not a new market-driven decision.
  2. Non-Market Transaction: The disposition was a gift (Code G) with a value of $0, providing no price signal.
  3. Immaterial Size: The 225 shares involved are insignificant relative to the company's market cap and total shares outstanding.

Additional Context

Special Circumstances

  • A footnote clarifies the filing's purpose: to report a transfer from a joint account that the reporting person was not aware of when it happened. This filing corrects the previously overstated holdings.
Topics:#SECFiling#UTHR#Form4#InsiderTrading#UnitedTherapeutics#StockMarket#Investing#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.